FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to drugs and concerns application of 9-dialkylaminoethylsubsituted-2-(4-fluorophenyl)imidazo[1,2]benzimidazole dihydrochloride of general formula I 
(where NR2 has the values specified in the formula) as a kappa-opioid the agonist.
EFFECT: invention aims at extending the range of products exhibiting kappa-opioid agonistic activity.
2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SALTS OF 9-(2-MORPHOLINOETHYL)-2-(4-FLUOROPHENYL)IMIDAZO [1,2-a]BENZIMIDAZOLE AND SALTS OF 9-AMINOETHYL-SUBSTITUTED -(4-FLUOROPHENYL)IMIDAZO [1,2-a]BENZIMIDAZOLE, HAVING ANALGESIC ACTION | 2009 |
|
RU2412187C1 |
| 9-SUBSTITUTED 2-HALOGENPHENYLIMIDAZO[1,2-a]BENZIMIDAZOLE SALTS AND 1-SUBSTITUTED 3-HALOGENPHENACYL-2-AMINOBENZIMIDAZOLIUM HALIDES POSSESSING HEMORHEOLOGICAL PROPERTIES | 2005 |
|
RU2290404C1 |
| AGENT POSSESSING TOPICAL ANESTHETIC EFFECT | 2006 |
|
RU2313341C1 |
| MEDICATIONS EXHIBITING PROPERTIES OF ANTAGONISTS OF SEROTONIN 5-HT- RECEPTORS | 2011 |
|
RU2465901C2 |
| PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY IN INJECTION FORM (VERSIONS) | 2013 |
|
RU2563211C2 |
| AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
| ANTICONVULSANT | 2014 |
|
RU2572711C1 |
| PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
| 9-SUBSTITUTED-2-BIPHENYLIMIDAZO[1,2-A]BENZIMIDAZOLES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, HAVING ANTIOXIDANT AND ANTIRADICAL PROPERTIES | 2017 |
|
RU2649979C1 |
| ANTITHROMBOTIC AGENT AFFECTING REGULATION OF THROMBOCYTE CAPACITY | 2008 |
|
RU2377990C1 |
